Clinical Guides
Cellulitis and Erysipelas
A clinically focused clinical guide to cellulitis and erysipelas in Indian practice, covering clinical diagnosis, mimics, necrotising infection and sepsis, portals of entry, oedema, oral and intravenous treatment decisions, local resistance, recurrence prevention, diabetes, immunosuppression and evidence limits.
MedNext Academy | 13 min read
Cellulitis and Erysipelas
A clinically focused clinical guide to cellulitis and erysipelas in Indian practice, covering clinical diagnosis, mimics, necrotising infection and sepsis, portals of entry, oedema, oral and intravenous treatment decisions, local resistance, recurrence prevention, diabetes, immunosuppression and evidence limits.
Summary
Cellulitis and erysipelas are acute spreading bacterial infections of skin and superficial soft tissue. Terminology varies: erysipelas usually describes a more superficial, raised and sharply demarcated process involving superficial lymphatics, whereas cellulitis extends more deeply through dermis and subcutaneous tissue. In practice they overlap. Typical findings are unilateral warmth, tenderness, swelling and expanding erythema, sometimes with fever, lymphangitis or regional nodes. Redness may be subtle in deeply pigmented skin, so compare temperature, oedema, tenderness and texture as well as colour.
Diagnosis is clinical and must include severity assessment and a search for the portal of entry, such as fissured toe webs, tinea pedis, eczema, ulcer, wound, bite, injection or oedema-related skin breakdown. Bilateral red legs are more often venous, lymphatic or inflammatory than bacterial. A fluctuant focus suggests abscess requiring drainage rather than antibiotic treatment alone. Pain out of proportion, rapid progression, toxicity, bullae, ecchymosis, crepitus or anaesthesia raises necrotising infection and demands immediate surgical escalation.
Most clinically stable patients who can absorb medicines can start oral therapy directed at streptococci and, according to context, methicillin-susceptible Staphylococcus aureus. Intravenous therapy is for severe systemic illness, inability to take oral drugs, deep or special-site infection, rapid progression or failed oral management, with review for oral switch as soon as safe. Agent and dose must follow the current local Indian policy, allergies, renal and hepatic function, pregnancy, exposure and antibiogram. Treat oedema and portals of entry to reduce recurrence. This educational draft is reviewed and has been reviewed by the MedNext Clinical Team.
How Common Is It?
Cellulitis is a common reason for community consultation and hospital antibiotic use, but robust contemporary national incidence data for India are limited. Hospital series are shaped by referral thresholds, diabetes prevalence, tropical exposures, antimicrobial access and the distinction between cellulitis, abscess and infected ulcer. Studies using discharge codes also inherit diagnostic error because venous stasis dermatitis and other red-leg syndromes are frequently labelled cellulitis. A local hospital percentage should therefore not be promoted as an Indian national rate.
The lower limb is the most frequent site in adults. Recurrent disease is concentrated among people with persistent oedema, lymphoedema, venous insufficiency, obesity, previous cellulitis, toe-web disease or chronic skin disruption. Diabetes increases the chance of complicated wounds and unusual infection contexts, but uncomplicated non-purulent cellulitis in a person with diabetes is not automatically polymicrobial. Facial, periorbital, hand and genital infections are less common but may require different pathways because function, anatomy and deeper spread matter.
Burden includes more than case counts. Delayed presentation, out-of-pocket medicine costs, informal antibiotic use, travel to a facility capable of intravenous therapy or surgery, and lost wages can influence severity at care. Conversely, overdiagnosis creates avoidable broad-spectrum exposure and admission. Service planning should track confirmed diagnoses, abscess drainage, sepsis, necrotising infection, recurrence, antimicrobial susceptibility and treatment failure separately. For an individual, tempo and physiological state are more important than how common the label is.
Risk Factors
Bacteria usually enter through a breach in the skin barrier, which may be too small to notice. Examine for interdigital fissures or maceration, tinea pedis, eczema, excoriation, ulcer, trauma, surgical wound, injection site, pressure damage, insect bite and animal or human bite. Recent freshwater or seawater exposure, soil contamination and penetrating injury change the possible organisms. Previous cellulitis can damage lymphatic drainage and increase further risk, creating a cycle of infection and oedema.
Chronic oedema is a major modifiable driver whether caused by lymphoedema, venous insufficiency, obesity, immobility, heart or renal disease, or previous surgery and radiotherapy. Diabetes contributes through skin barrier problems, neuropathy, ulcers, vascular disease and impaired host response. Do not call an ulcer-associated diabetic foot infection simple cellulitis; it needs depth, perfusion, bone and multidisciplinary foot assessment. Other risk contexts include immunosuppressive medicines, neutropenia, malignancy, advanced HIV, cirrhosis, injecting drug use and asplenia, with pathogen and urgency adjusted to the actual deficit.
Age, frailty and limited ability to inspect or clean the feet can delay detection. Shaving, cosmetic procedures and unregulated injections may create portals. MRSA risk depends on prior colonisation or infection, recent healthcare exposure, purulence, penetrating trauma and local epidemiology; it is not inferred solely from treatment failure. Antibiotic use itself selects resistance. Prevention therefore combines skin care, treatment of fungal or inflammatory disease, oedema control, appropriate footwear, wound care and narrow, reviewed antimicrobial use rather than indefinite empirical broad coverage.
Diagnosis
History
Establish onset, speed of spread, pain, fever, rigors, malaise and prior episodes. Ask about trauma, surgery, ulcer, dermatitis, toe-web symptoms, bite, water or soil exposure, injection, travel, recent antibiotics and known resistant organisms. Record diabetes, neuropathy, vascular disease, oedema, lymphatic surgery, malignancy, neutropenia, HIV, immunosuppressants, renal and hepatic disease, pregnancy and drug allergy. Severe pain before striking skin change or rapid deterioration is a necrotising-infection warning. Clarify whether swelling is unilateral and whether venous symptoms preceded redness.
Examination
Assess airway, breathing, circulation, mental state, temperature, pulse, blood pressure, respiratory rate, oxygen saturation and perfusion before concentrating on the rash. Expose the entire limb or site; mark the border with date and time when useful. Document warmth, tenderness, oedema, distribution, lymphangitis, nodes, bullae, purpura, crepitus, fluctuance, drainage, ulcer depth and the portal of entry. Compare both limbs and inspect between toes. Evaluate joint movement, tendon pain, distal pulses, sensation and compartment tension. Darker skin may show violaceous or subtle colour change; palpation and systemic assessment are essential.
Investigations
Typical mild cellulitis needs no routine culture or imaging. Swab only broken or draining skin when the result could change treatment, especially after penetrating injury, water exposure, overseas acquisition or prior resistant organisms. Culture pus from an abscess. Obtain blood cultures for severe systemic features, immunocompromise or unusual exposure, ideally before antibiotics without delaying emergency treatment. Full blood count, renal and liver function, glucose, lactate and inflammatory markers support severity and prescribing but neither confirm nor exclude disease. Ultrasound helps when abscess or deep-vein thrombosis is uncertain. Imaging must not delay surgical exploration when necrotising infection is suspected.
Differential Diagnosis
Venous stasis dermatitis is commonly bilateral, chronic, itchy or scaly and associated with oedema, varicosities and haemosiderin change; it can flare acutely and be mistaken for infection. Lipodermatosclerosis produces painful induration and an inverted-bottle contour. Lymphoedema, dependent rubor and heart-failure oedema can be warm or erythematous without bacteria. Contact dermatitis follows exposure and often has sharp geometric borders, itch or vesiculation. Gout, pseudogout and inflammatory arthritis centre on a joint, while superficial thrombophlebitis follows a tender cord. Deep-vein thrombosis can coexist and is assessed by validated clinical pathways rather than redness alone.
Abscess has a purulent focus, fluctuance or ultrasound collection; drainage is central. Infected eczema, impetigo, erythema migrans, herpes zoster, erythema nodosum, vasculitis and fixed drug eruption have different morphology or histories. Acute limb ischaemia can cause pain and mottling with poor perfusion. Compartment syndrome produces escalating pain, tense swelling and pain with passive stretch. Septic arthritis, osteomyelitis, pyomyositis and infectious tenosynovitis are deeper infections requiring targeted evaluation.
Necrotising fasciitis is the dangerous mimic or complication: pain out of proportion, rapid progression, oedema beyond visible erythema, systemic toxicity, wooden induration, bullae, ecchymosis, anaesthesia, crepitus or shock should trigger immediate surgical review. A low laboratory risk score cannot safely rule it out. Orbital cellulitis produces painful or restricted eye movements, proptosis or visual dysfunction and follows an emergency ophthalmic pathway. Diabetic foot infection, bite wounds and water-associated infection require separate organism and source-control thinking. Diagnostic uncertainty should prompt review, not automatic broadening of antibiotics.
Management
First decide whether the patient has uncomplicated non-purulent cellulitis, a collection needing drainage, a deep infection needing surgery, or sepsis requiring resuscitation. Mark and photograph the border under appropriate consent and governance, elevate the limb, provide analgesia, maintain hydration and address the portal of entry. Treat tinea, eczema, wound or oedema alongside the acute infection, but avoid compression over a severely painful acutely inflamed limb until arterial status, comfort and specialist advice are considered. Arrange review if symptoms fail to begin improving within two to three days or worsen at any time.
For clinically stable patients who can swallow and absorb medicine, oral treatment is preferred. Choose an agent active against streptococci and, when indicated, MSSA using the current local antimicrobial guideline. Purulence, previous MRSA, penetrating trauma or a documented local risk changes coverage; routine anti-MRSA or broad gram-negative therapy for every case is poor stewardship. Abscesses require incision and drainage when anatomically safe. Diabetes alone does not justify maximal-spectrum therapy, but an ulcer, necrosis, ischaemia or deep foot involvement changes the diagnosis and pathway.
Use intravenous treatment when the patient is severely unwell, cannot take or absorb oral therapy, has rapidly progressive or special-site disease, requires hospital observation, or has failed appropriate oral management. Reassess within about forty-eight hours and switch to oral therapy when physiology, local findings and absorption permit. Suspected necrotising infection needs immediate surgical exploration and broad intravenous treatment; antibiotics cannot replace source control. Recurrent episodes require oedema control, skin care and portal treatment. Antibiotic prophylaxis is specialist-led, reserved for selected frequent recurrence after modifiable factors are addressed, and reviewed for benefit and resistance.
Prescribing Information
Verify severity, purulence, site, exposure, allergy phenotype, prior cultures, pregnancy, age, weight, renal and hepatic function, interactions and local susceptibility before prescribing. ICMR's 2019 common-syndrome guidance lists cefazolin, cephalexin or amoxicillin-clavulanate among Indian options for cellulitis and advises considering polymicrobial pathogens in relevant diabetic presentations and MRSA risk before adding coverage. It is a national reference, not a substitute for a current institutional antibiogram or an individual prescription. Local policies may prefer different narrow agents as resistance and supply change.
An uncomplicated non-purulent case generally needs streptococcal coverage; include MSSA according to policy. Do not add anti-MRSA, anaerobic or gram-negative therapy without a clinical reason. Bites, water exposure, necrosis, diabetic foot ulcer, neutropenia and severe immunosuppression follow different protocols. Intravenous therapy should have a daily indication and an oral-switch plan. Dose adjustment, infusion monitoring and therapeutic drug monitoring may be necessary for renally cleared or toxic agents. Record the allergy reaction rather than only the word penicillin.
Current guidelines recommends oral first-line treatment when severity permits, review of intravenous treatment by forty-eight hours, and commonly five-to-seven-day courses with extension based on response. Those named drugs and doses are UK guidance and must not be copied uncritically into India. Avoid topical antibiotics for intact-skin cellulitis. Counsel that surface redness can resolve slowly even after infection responds, but rapid spread, new systemic illness or failure to improve requires reassessment. Prophylactic antibiotics for recurrence are specialist decisions with six-monthly review and explicit resistance discussion.
When to Refer
Refer to hospital immediately for suspected necrotising fasciitis, sepsis, haemodynamic instability, altered mental state, rapidly progressive infection, severe pain out of proportion, bullae, ecchymosis, crepitus, anaesthesia, deep abscess, compartment syndrome, septic arthritis, osteomyelitis or limb-threatening ischaemia. Facial infection near the eye or nose, orbital signs, hand infection with tendon or compartment concern, genital or perineal infection and infection over an implanted device deserve specialist pathways. Do not delay surgery for imaging or a response to the first antibiotic when necrotising infection is plausible.
Consider hospital or specialist assessment when the patient is severely unwell, cannot take oral medicine, has spreading disease despite appropriate therapy, lymphangitis, significant immunosuppression, neutropenia, unusual exposure, recurrent treatment failure or inadequate support for safe community review. Diabetic foot ulcer with infection requires an urgent multidisciplinary foot pathway, especially with necrosis, ischaemia, systemic illness or suspected bone involvement. Children, pregnancy and frail older adults need age- and physiology-appropriate thresholds.
Routine referral is useful for repeated cellulitis with chronic oedema or lymphoedema, unclear diagnosis, persistent ulcer or suspected underlying inflammatory or vascular disease. Provide site, extent and rate of spread, observations, portal of entry, comorbidity, allergies, exposure, previous organisms and antibiotics, renal function and response. In India, confirm whether the destination can provide surgery, imaging, microbiology and intravenous monitoring. A paper referral without transport, early review or escalation instructions is not a safe plan.
Red Flags
Necrotising soft-tissue infection must be considered when pain is severe or disproportionate, progression is measured in hours, oedema or tenderness extends beyond visible change, tissues feel wooden, or bullae, ecchymosis, skin anaesthesia, crepitus, necrosis or systemic toxicity appears. These features may be late, and absence of gas does not reassure. Urgent senior surgical assessment, resuscitation, cultures and broad intravenous antimicrobial therapy proceed together; neither CT nor an LRINEC score should delay exploration when clinical suspicion is high.
Sepsis red flags include altered consciousness, hypotension, tachypnoea, hypoxaemia, oliguria, mottling, poor peripheral perfusion, rising lactate or rapid deterioration. Fever may be absent in older, immunosuppressed or severely ill patients. Orbital warning signs are proptosis, painful or restricted eye movement, diplopia, reduced visual acuity, colour desaturation or an afferent pupillary defect. A painful swollen joint, tendon-sheath signs, loss of distal perfusion or a tense compartment requires a different emergency pathway.
In diabetes or immunosuppression, modest surface change can conceal deep infection. Ulcer depth, necrosis, gas, exposed bone, new glycaemic instability or unexplained systemic illness increases urgency. Failure to improve may reflect the wrong diagnosis, an undrained collection, resistant organism, inadequate dose or absorption, poor perfusion or non-adherence; simply stacking antibiotics is unsafe. New blistering or mucosal disease after medication raises a severe drug reaction rather than infection progression. Every community plan must state who reviews the patient and exactly what deterioration triggers immediate return.
Indian Clinical Context
Indian practice must combine national stewardship principles with local microbiology. ICMR guidance provides a syndrome-based reference, but resistance varies between regions, hospitals and community settings, and an antibiogram from one tertiary centre cannot be generalized across India. Empirical choice should follow the current facility policy, prior patient cultures and exposure. Where microbiology is unavailable, narrow treatment for the most likely syndrome with scheduled clinical reassessment is safer than uncontrolled broad combinations. Over-the-counter or incomplete antibiotic courses can obscure response, select resistance and complicate allergy histories.
Diabetes is an important context, particularly when neuropathy, ulceration, peripheral arterial disease or renal impairment is present. A red diabetic foot is not automatically simple cellulitis: remove footwear and dressings, assess depth, perfusion, sensation, deformity, necrosis, abscess and bone involvement, then use the local diabetic-foot pathway. Chronic lymphatic or venous oedema also needs long-term care, yet compression access and fitting expertise vary. Skin hygiene, emollients, toe-web treatment, suitable footwear and oedema management can be more preventive than repeated antibiotics.
Access decisions include distance to a surgical service, capacity for forty-eight-hour intravenous review, cost of laboratory testing and whether the patient can return if worse. Outpatient intravenous therapy is safe only with selection, monitoring and rapid escalation capability. Written advice should account for language and skin pigmentation. international and IDSA evidence informs principles but does not dictate Indian products or referral thresholds. Document the actual pathway and resistance source used, and acknowledge when evidence for immunocompromised, tropical-exposure or recurrent cases is extrapolated.
NMC Competency Mapping
The NMC CBME Curriculum 2024 maps skin and soft-tissue infection most directly to Microbiology MI5.3, which covers etiopathogenesis, clinical course and laboratory diagnosis of bacterial, fungal, viral and parasitic skin and soft-tissue infections. MI5.4 requires differentiation of infective and non-infective skin lesions. Pharmacology PH8.1 and PH8.2 cover antimicrobial resistance, rational antimicrobial use and stewardship. General Surgery SU6.1 and SU6.2 cover surgical infection and planning prophylactic and therapeutic antibiotics. These are related integrated outcomes; the curriculum does not identify legacy SU4.1 as cellulitis, because SU4.1 concerns burn pathophysiology.
An undergraduate should recognise typical unilateral cellulitis, identify a portal, grade physiology, distinguish abscess from non-purulent infection and name venous, inflammatory, vascular and thrombotic mimics. The student must recognise sepsis, orbital infection, diabetic-foot disease and necrotising fasciitis, knowing that disproportionate pain and rapid progression override a reassuring laboratory score. Specimen teaching should explain why intact-skin swabs are low yield and when pus, blood or tissue cultures change care.
Prescribing assessment should test syndrome, likely organisms, allergy, route, renal function, local resistance, duration and oral-switch review rather than a memorized brand. Surgical source control and antimicrobial stewardship should be examined together. Supervised bedside learning is required for perfusion, compartment, orbital and deep-infection assessment; this guide cannot certify those skills. Institutions should confirm codes against their current curriculum and logbook.
Key Exam Pearls for NEET PG
Erysipelas is classically more superficial, raised and sharply demarcated, while cellulitis involves deeper dermis and subcutaneous tissue; overlap is common. Non-purulent cellulitis is usually streptococcal, with MSSA considered by clinical context. Purulence suggests abscess or staphylococcal disease and makes drainage central. Typical intact-skin cellulitis does not need a surface swab. Blood or tissue cultures are reserved for severe systemic illness, immunocompromise or unusual exposures. Always examine toe webs and look for oedema, venous disease, eczema, ulcer or trauma.
Bilateral red legs favour stasis dermatitis, lymphoedema or another inflammatory process over bacterial cellulitis. Marking the border supports review but does not measure depth. Ultrasound can identify an occult collection or support a DVT pathway. Pain out of proportion, rapid spread, wooden induration, bullae, ecchymosis, anaesthesia, crepitus, shock or oedema beyond erythema indicates necrotising infection until assessed surgically. Imaging and LRINEC cannot safely rule it out or delay operation.
Use oral antibiotics first when the patient is stable and can absorb them. Intravenous therapy is for severe illness, inability to take oral medicine, special-site or rapidly progressive disease, or treatment failure; review by about forty-eight hours for oral switch. Recurrence prevention means treating portals and chronic oedema, not reflex permanent antibiotics. For NMC, remember MI5.3 and MI5.4 for infective versus non-infective lesions, PH8.1-PH8.2 for stewardship, and SU6.1-SU6.2 for surgical infection. SU4.1 is burns, not cellulitis.
Frequently Asked Questions
Does every red swollen leg need antibiotics for cellulitis?
No. Venous stasis dermatitis, lymphoedema, contact dermatitis, gout, thrombosis and other disorders can mimic cellulitis, especially when both legs are affected. Diagnosis requires unilateral warmth, tenderness, progression and context, plus severity assessment. Uncertainty should trigger planned review or specialist advice, not automatic broad-spectrum treatment.
When should cellulitis be treated with intravenous rather than oral antibiotics?
Intravenous treatment is appropriate for severe systemic illness, inability to swallow or absorb medicine, rapid progression, special-site or deep infection, or failure of appropriate oral treatment. It should be reviewed within about forty-eight hours, with oral switch when physiology and local findings improve and absorption is reliable.
Which features suggest necrotising infection rather than uncomplicated cellulitis?
Severe pain out of proportion, progression over hours, tenderness or oedema beyond visible redness, wooden induration, bullae, ecchymosis, skin anaesthesia, crepitus, necrosis or systemic toxicity are critical warnings. Immediate surgical assessment is required; imaging or a low laboratory risk score must not delay exploration when suspicion is high.
How can recurrent cellulitis be prevented?
Identify and treat portals such as tinea, toe-web fissures, eczema, wounds and ulcers; manage chronic oedema or venous disease; support skin care, footwear and weight management where relevant; and optimize diabetes care. Antibiotic prophylaxis is not routine and should be a specialist, reviewed decision for selected frequent recurrences after modifiable factors are addressed.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic